Operating as an investor and operator with a focus on technology-driven business models, Chad Whiteley is known for early-stage investing, board-level operational oversight and go-to-market scaling of SaaS and fintech companies. The profile emphasizes capital allocation, strategic partnerships and revenue growth initiatives; experience spans fundraising, M&A advisory and interim executive roles. Market relevance centers on startup diligence, growth-stage governance and aligning product-led GTM with measurable KPIs for investors.
Operating as an investor and operator with a focus on technology-driven business models, Chad Whiteley is known for early-stage investing, board-level operational oversight and go-to-market scaling of SaaS and fintech companies. The profile emphasizes capital allocation, strategic partnerships and revenue growth initiatives; experience spans fundraising, M&A advisory and interim executive roles. Market relevance centers on startup diligence, growth-stage governance and aligning product-led GTM with measurable KPIs for investors.
Operator-investor approach prioritizing early and growth-stage technology companies, with emphasis on SaaS and fintech models. Capital deployment favors founder-led teams with product-market fit and measurable unit economics; underwriting focuses on GTM scalability, CAC/LTV dynamics and recurring revenue predictability. Active board involvement and interim executive support accelerate commercialization and fundraising outcomes. Portfolio decisions balance capital efficiency with follow-on reserves, a 3–7 year growth horizon, and strict metric-driven risk controls to de-risk scaling and exit timing.
Operator-investor approach prioritizing early and growth-stage technology companies, with emphasis on SaaS and fintech models. Capital deployment favors founder-led teams with product-market fit and measurable unit economics; underwriting focuses on GTM scalability, CAC/LTV dynamics and recurring revenue predictability. Active board involvement and interim executive support accelerate commercialization and fundraising outcomes. Portfolio decisions balance capital efficiency with follow-on reserves, a 3–7 year growth horizon, and strict metric-driven risk controls to de-risk scaling and exit timing.
| Trades 1690 | Longs Won 1106/1690 65% | Profit Factor 4.29 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.38M |
| Average Win $425,817.76 | Best Trade (Sep 08) $32.8M | Sharpe Ratio -9.54 |
| Average Loss -$187,977.32 | Worst Trade (Jun 29) -$5.27M | Z-Score 3.5 (99.95%) |
| Commissions $0 | Avg. Trade Length 10m 1w 6d | Expectancy $213,607.16 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,545 | 4,091 | 3,636 | 3,182 | 2,727 | 2,273 | 1,818 | 1,364 | 909 | 455 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 106,629 | $21.71M | $32.94M | - | $11.23M | 51.7% | -7.354% |
ABBV AbbVie Inc. | 17,459 | $2.99M | $4.38M | - | $1.39M | 46.61% | -2.513% |
ABT Abbott Laboratories | 3,500 | $381,530.53 | $369,950 | - | -$11,580.53 | -3.04% | +0.085% |
ADI Analog Devices, Inc. | 5,841 | $1.44M | $2.15M | - | $709,526.77 | 49.39% | +0.202% |
ADM Archer-Daniels-Midland Co | 35,069 | $1.99M | $2.78M | - | $787,638.11 | 39.53% | -1.662% |
AEP American Electric Power Company, Inc. | 8,059 | $740,727.39 | $1.03M | - | $289,615.76 | 39.1% | +0.055% |
AGL Agilon Health Inc. | 31,143 | $3.59M | $2.85M | - | -$733,106.22 | -20.44% | -5.313% |
AGX Argan Inc. | 1,600 | $1.28M | $912,687.98 | - | -$364,992.02 | -28.57% | -1.628% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 92,645 | $6.31M | $28.83M | - | $22.52M | 356.72% | +3.851% |
ALB Albemarle Corporation | 5,487 | $978,540.42 | $645,490.68 | - | -$333,049.74 | -34.04% | -0.102% |
ALNY Alnylam Pharmaceuticals Inc | 41,684 | $13.45M | $8.57M | - | -$4.89M | -36.32% | +0.019% |
AMD Advanced Micro Devices, Inc. | 3,969 | $655,818.68 | $1.89M | - | $1.23M | 188.16% | -1.904% |
AMN Amn Healthcare Services Inc. | 54,008 | $1.75M | $1.82M | - | $68,050.04 | 3.89% | -3.111% |
AMZN Amazon.com Inc | 82,140 | $14.05M | $22.31M | - | $8.26M | 58.81% | +15.321% |
ANDE The Andersons, Inc. | 12,967 | $886,943 | $917,804.26 | - | $30,861.26 | 3.48% | -1.035% |
ANET Arista Networks, Inc. | 89,314 | $9.06M | $16.11M | - | $7.05M | 77.81% | +5.456% |
APD Air Products and Chemicals, Inc. | 3,532 | $1.04M | $1.04M | - | $6,039.52 | 0.58% | -1.769% |
APP AppLovin Corporation Class A Common Stock | 24,803 | $15.05M | $9.82M | - | -$5.23M | -34.77% | -1.973% |
AVGO Broadcom Inc. | 9,093 | $1.63M | $3.54M | - | $1.91M | 117.45% | +0.371% |
BA Boeing Company | 38,824 | $7.77M | $8.39M | - | $620,625.9 | 7.99% | -2.155% |